Starry Group Holdings (NYSE:STRY) announced this morning that it will be reducing the warrant exercise price and adjusting the redemption trigger price as a result of the Crescent Term being triggered.
Ahead of the shareholder vote for the FirstMark Horizon and Starry deal, a number of changes were made to the transaction, including increasing its PIPE size from $130 million to $140 million. It also adjusted the per share PIPE price from $10.00 to $7.50, both of which called the Crescent Term into play.
The Crescent term stipulates that it will be triggered based on three main criteria. For one, if the PIPE size and proceeds represent more than 60% of the issued equity in the deal. The second criteria is if the pre share price of any PIPE is struck below $9.20. The third criteria kicks in if the combined company trades below $9.20 for a 20 of 30 trading days VWAP beginning on the day preceding the closing of the combination. For Starry, it triggered the first two when it announced the re-struck PIPE, but investors had to wait 30 days for the VWAP, which came in at approximately $7.92.
As a result, Starry will reduce the warrant exercise price from $11.50 per 1.2415 shares to $9.13 per 1.2415 shares. The company will also reduce the $18.00 per share redemption trigger price to $14.29 per share and adjust the $10.00 per share redemption trigger price to $7.94 per share. Each of these adjustments was effective as of the close of trading on Friday, April 22, 2022.
The Crescent Term’s “PIPE protection” represents a major advantage for warrant holders in situations such as this and gives Sponsors and target companies flexibility to amend their PIPE agreements while minimizing harm to investors.
As background, Starry completed its business combination with FirstMark Horizon Acquisition Corp. last month on March 18. FirstMark initially announced its $1.6 billion combination with the internet service provider last year on October 7.
December 2024 corporate actions continues the trend of SPAC teams seeking additional extensions beyond their third round, as they work to close their combinations with the remaining funds after redemptions. Despite this activity, both announcements and corporate actions associated with completion votes were notably few this month. Extension Votes In December, there were 26 scheduled...
At the SPAC of Dawn 2025 dawns with a reminder to SPAC teams that, as the Rolling Stones song goes, “You can’t always get what you want.” That was the message sent by Aimei Health I (NASDAQ:AFJK) shareholders as they rejected a proposal to reduce the SPAC’s monthly contribution to trust for the duration of...
An In-Depth Look at SPAC Activity Throughout the Full-Year of 2024 Below is a summary of the Full-Year 2024 SPAC market. If you’d like a pdf copy, you access the link HERE. SPACs have emerged from 2024 with a cautious optimism that feels both hard-earned and fragile. After weathering the turbulence of the past few...
The next quarter century is starting off with a set of de-SPAC shareholders newly able to realize better gains as their lock-ups expire in January than most months through 2024. Eight de-SPACs and six sponsors are to see their shares unlocked next month, and while none of these companies finished trading on December 30 in...
Maywood Acquisition Corp. (NASDAQ:MAYAU) filed to list a $75 million SPAC on the penultimate day of 2024 with a CEO making his second rodeo and a focus on serving the demand for listing opportunities and exits in Asia-Pacific. This new SPAC is not overfunding its trust and will have rights to a 1/5 share in...